Drugs

5AM Ventures is a leading life science venture capital firm focused on funding and building next-generation life sciences companies. They primarily invest in early-stage private therapeutic companies, with an emphasis on Series A, and also invest in small and mid-cap public and later-stage private biotech and life science companies.

Adjuvant Capital is a life sciences investment fund that backs ambitious companies developing drugs, vaccines, diagnostics, medical devices, and other technologies to address critical global public health challenges. It focuses on historically overlooked market segments, leveraging expertise to translate opportunities into social and financial returns. The firm's investment model is heavily influenced by global trends such as climate change and antimicrobial resistance.

Hikma Ventures is the strategic venture capital arm of Hikma Pharmaceuticals, investing in innovative digital health and life sciences companies worldwide. They invest in disruptive technologies and meaningful companies with a diverse leadership team. Their investment mandate is broad, focusing on areas where they see strategic advantages for both Hikma and their portfolio companies.

ScaleX Ventures invests in exceptional founders from unexpected places, supporting their journey to global success. They provide resources and a platform to help founders overcome challenges and achieve significant growth. ScaleX partners with its portfolio companies, sharing in their success.